27P Durability of efficacy and safety with selpercatinib in patients (pts) with RET fusion+ non-small cell lung cancer (NSCLC)
Titel:
27P Durability of efficacy and safety with selpercatinib in patients (pts) with RET fusion+ non-small cell lung cancer (NSCLC)
Auteur:
Drilon, A. Subbiah, V. Gautschi, O. Tomasini, P. De Braud, F.G.M. Solomon, B. Shao-Weng Tan, D. Alonso, G. Wolf, J. Park, K. Goto, K. Soldatenkova, V. Szymczak, S. Barker, S. Puri, T. Lin, A.B. Loong, H.H.F. Besse, B.